Governance and Guiding Principles

Governance

iPRI’s guiding principles are Independence, Transparency, Integrity, Impartiality and Timing.

The independent International Governance and Ethics Committee — IGEC — is responsible for giving advice and guidance to iPRI in the selection of studies to be conducted by iPRI and to bring its global expertise to assist with difficult or controversial issues within applications presented.

Its Governance role is to further:

  • give advice and guidance to iPRI in the selection of studies to be conducted by iPRI
  • certify and confirm that processes within iPRI are followed and executed properly by individuals qualified to oversee these processes
  • interrogate the independence and transparency of iPRI research notably in the context of any studies financed by a private sector entity

Ethics

The International Governance and Ethics Committee — IGEC — has a major responsibility to expedite the appropriate ethical review of all research proposals involving iPRI.

All studies iPRI is performing are based on scientific excellence and undergo strict ethical review. The ethical review is performed by IGEC.

External Guidelines

The IGEC follows all established international ethics recommendations including:

All scientific findings are sent for publication in peer-reviewed journals. Specific provisions are made for avoiding any role of public and private sponsors in reporting of scientific findings.

iPRI recognizes the following documents as additional guidelines:

Declaration of Helsinki

The Declaration of Helsinki is a set of ethical principles regarding human experimentation developed for the medical community by the World Medical Association (WMA). It is widely regarded as the cornerstone document on human research ethics. These articles are of particular relevance to iPRI studies:

(1) The World Medical Association (WMA) has developed the Declaration of Helsinki as a statement of ethical principles for medical research involving human subjects, including research on identifiable human material and data.

(6) The primary purpose of medical research involving human subjects is to understand the causes, development and effects of diseases and improve preventive, diagnostic and therapeutic interventions (methods, procedures and treatments). Even the best proven interventions must be evaluated continually through research for their safety, effectiveness, efficiency, accessibility and quality.

(16) Medical research involving human subjects may only be conducted if the importance of the objective outweighs the risks and burdens to the research subjects.

(21) Medical research involving human subjects must conform to generally accepted scientific principles, be based on a thorough knowledge of the scientific literature, other relevant sources of information, and adequate laboratory and, as appropriate, animal experimentation.

(24) Every precaution must be taken to protect the privacy of research subjects and the confidentiality of their personal information.

(26) In medical research involving human subjects capable of giving informed consent, each potential subject must be adequately informed of the aims, methods, sources of funding, any possible conflicts of interest, institutional affiliations of the researcher, the anticipated benefits and potential risks of the study and the discomfort it may entail, post-study provisions and any other relevant aspects of the study.

(27) Researchers, authors, sponsors, editors and publishers all have ethical obligations with regard to the publication and dissemination of the results of research. Researchers have a duty to make publicly available the results of their research on human subjects and are accountable for the completeness and accuracy of their reports. All parties should adhere to accepted guidelines for ethical reporting. Negative and inconclusive as well as positive results must be published or otherwise made publicly available.

Committee Members

iPRI’s International Governance and Ethics Committee members are:
  • Mr. David Byrne — Chairman
  • Professor Clement Adebamowo
  • Professor Kazem Behbehani
  • Professor Charles Gillis
  • Ambassador Mireille Guigaz
  • Lord James MacKay of Clashfern
  • Professor Edith Olah
  • Professor Luis Pinillos Ashton
  • Maître Jean-Luc Soulier
  • Professor Andrzej Wojtyla

Discover iPRI

What we do, who we are and who we do it with. 

Approach

iPRI represents a new concept in biomedical research combining a thorough, high-level, academic approach coupled with a practical focus on providing evidence-based information about clinical, epidemiological and prevention strategies.

People

iPRI faculty, research fellows and staff are internationally recognized for their methods, conclusions and extensive publications in journals worldwide.

Partners

iPRI is proud of its long term relationships with like-minded organisations and corporations, most notably leading academic and scientific research institutions.

Mission

Founded in 2009 with the broad goal of contributing to the improvement of health in populations worldwide, the International Prevention Research Institute (iPRI) aims to increase prospects for prevention through training, education, prevention research and research into causes worldwide with a focus on low and lower-middle income countries.

iPRI strives to answer three critical questions:

  • Is it healthy?
  • Is it safe?
  • Is it beneficial?

Contact iPRI

An iPRI staff member will reply promptly